Literature DB >> 6313331

Binding of radioiodinated parathyroid hormone to cloned bone cells.

R E Rizzoli, M Somerman, T M Murray, G D Aurbach.   

Abstract

We have investigated the binding of biologically active radioiodinated bovine PTH-(1-84) to cloned osteoblast-like rat osteosarcoma cells (ROS 17/2.8) and correlated binding with biological response assessed as cAMP production. The hormone was labeled with 125I on tyrosine-43 using a constant current microelectrolytic method which allows full retention of biological activity. At confluency, cells were removed from culture, and assays were carried out on intact cells in suspension. At 22 C, saturable binding reached equilibrium by 90 min. At that time, the apparent dissociation rate constant was 8 X 10(-8) min-1. At an earlier time, 10 min of incubation, the dissociation rate was twice that observed at equilibrium. Nonsaturable binding was 30-35% of the total binding. The dissociation constant derived from kinetic analysis was 41 nM and correlated with the half-maximal cAMP production at 36 nM. The results obtained suggest that cleavage amino-terminal to residue 43 is not required for binding to these bone-derived cells. Binding to receptors on the osteosarcoma cells was specific and reversible, and appeared biologically relevant, since it correlated closely with the biological response, cAMP production. The competitive inhibitor [Nle8,Nle18,Tyr34]bPTH-(3-34)amide showed the same apparent affinity in inhibiting receptor binding as in inhibiting cAMP production.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313331     DOI: 10.1210/endo-113-5-1832

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Increase of adenylate cyclase catalytic-unit activity by dexamethasone in rat osteoblast-like cells.

Authors:  R Rizzoli; V von Tscharner; H Fleisch
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

2.  Structural requirements for parathyroid hormone action in mature bone. Effects on release of cyclic adenosine monophosphate and bone gamma-carboxyglutamic acid-containing protein from perfused rat hindquarters.

Authors:  M S Calvo; M J Fryer; K J Laakso; R A Nissenson; P A Price; T M Murray; H Heath
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

3.  Solubilization of functional receptors for parathyroid hormone and parathyroid hormone-related peptide from clonal rat osteosarcoma cells, ROS17/2.8.

Authors:  S Uneno; T Yamamuro; H Jüppner; A B Abou-Samra; H T Keutmann; J T Potts; G V Segre
Journal:  Calcif Tissue Int       Date:  1992-11       Impact factor: 4.333

4.  Dexamethasone-treated ROS 17/2.8 rat osteosarcoma cells are responsive to human carboxylterminal parathyroid hormone peptide hPTH (53-84): stimulation of alkaline phosphatase.

Authors:  T M Murray; L G Rao; S A Muzaffar
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

Review 5.  Parathyroid hormone-related protein and calcium phosphate metabolism.

Authors:  F Law; S Ferrari; R Rizzoli; J P Bonjour
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

6.  Study of the localization of [3H]bovine parathyroid hormone in bone by light microscope autoradiography.

Authors:  P M Barling; N J Bibby
Journal:  Calcif Tissue Int       Date:  1985-07       Impact factor: 4.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.